Stroman David W. 5/A
5/A · NovaBay Pharmaceuticals, Inc. · Filed Apr 2, 2012
Insider Transaction Report
Form 5/AAmended
Stroman David W.
SVP, Ophthalmic Product Devt.
Transactions
- Purchase
Common Stock
2007-10-25$4.00/sh+2,000$8,000→ 2,000 total
Footnotes (1)
- [F1]Dr. Stroman purchased 2,000 Common shares at the Company's IPO in October 2007 and he was not an employee of the Company at the time of the purchase. Dr. Stroman joined the Company in October 2011.